Atlas Trials

Ripretinib in Chinese Patients With Advanced GIST: a Real World Study

Clinical trial NCT05697107 · UNKNOWN

Trial details

NCT number
NCT05697107
Sponsor
Peking University
Status
UNKNOWN
Study type
OBSERVATIONAL
Gastrointestinal Stromal Tumors
Start date
2021-05-20
Primary completion
2022-08-30
Enrollment
308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.